Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DiMe Generated Content

Recommendations for Defining and Reporting Adherence Measured by Miometric Monitoring Technologies: Systematic Review

DiMe Research Committee working group reviews methods and definitions by which adherence has been captured and reported using BioMets in order to identify gaps and provide recommendations to the field.

July 28, 2022

Considerations for Conducting Bring Your Own “Device” (BYOD) Clinical Studies

DiMe Research Committee working group explores the potential, risks, and key considerations for organizations to consider when using a “BYOD” approach in clinical research

July 28, 2022

Industry Voices—Virtual care should address transition points in our fragmented system

In partnership with IMPACT member Wellinks, DiMe leadership discuss how virtual-first care can improve patient experience and engagement across the care journey and optimize handoffs between care settings

July 27, 2022

Your Guide To Harnessing Clinical Trial Sensor Data Better

DiMe CEO, Jen Goldsack, describes the imperative for preparing for the use of sensor data at scale

July 26, 2022

New Toolkit Aims to Support Effective Virtual-First Care Transitions

The Digital Medicine Society and American Telemedicine Association have developed a new toolkit to support the integration of virtual and in-person healthcare.

June 28, 2022

FDA Diversity Plan Clinical Trials

A letter submitted on behalf of the Digital Medicine Society (DiMe) for consideration by the U.S. Food and Drug Administration (FDA) regarding Docket No. FDA-2021-D-0789 for “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry; Availability .”

June 2022

View DiMe Comment

Outcomes of In-Person and Telehealth Ambulatory Encounters During COVID-19 Within a Large Commercially Insured Cohort

DiMe, Johns Hopkins, and BlueHealth Intelligence publish one of the first studies probing telehealth outcomes during the pandemic.

April 27, 2022

Why you should (virtually) care

DiMe leadership describe the opportunity of virtual-first care, or V1C, to increase the quality of healthcare and make it more patient-centric by letting patients combine in-person visits with virtual options such as video for seeing their care providers.

April 14, 2022

Using Digital Health Technologies in Remote Data Acquisition in Clinical Investigations

The FDA released a draft guidance regarding the use of digital health technologies in remote clinical investigation.

March 2022

View DiMe Comment

Advancing digital health applications: priorities for innovation in real-world evidence generation

DiMe and German Federal Ministry of Health publish global priorities for innovation in real-world evidence generation to advance digital health applications

DiMe responds to the White House OSTP RFI on DHTs

On behalf of the DiMe community, we submitted a response to the White House Office of Science and Technology Policy (OSTP) RFI highlighting the power of DiMe’s multi-stakeholder, interdisciplinary program delivery model to transform community health, individual wellness, and health equity. Connected community health requires meeting the needs of the community through services and improved knowledge for the community and those working with them. 

February 2022

View DiMe Comment

Putting Digital Health Innovation Into Practice: Learning From The VHA

DiMe and VA leadership defines characteristics of a value-chain approach to successful digital health innovation in practice

The year ahead in digital health and life sciences: the pharmaphorum podcast

DiMe CEO, Jen Goldsack, discusses anticipated 2022 trends in digital health and the life sciences with PharmaPhorum’s Jonah Comstock

Education, Partnerships, Technology and Opportunity The Building Blocks for Advancing DTx

DiMe Program Lead, Smit Patel, joins Megan Coder, Walter Greenleaf, Basker Gummadi, Dominick Kennerson and Loreen Brown at DTx Global Virtual Summit to discuss: “Embracing Digital Therapeutics and the Progressive Future of Digital Health”

Starting the journey towards Virtual First Care

DiMe COO, Claire Meunier, joins colleagues from Mercer to talk about virtual first care and the work IMPACT is doing to shape the field.

Copyright © 2022 The Digital Medicine Society (DiMe). All Rights Reserved.